register free | resend password

EuroLife Brands Secures $2.5 Million Credit Facility From European Equity Group

ID: 1555470
recent pressrelease next pressrelease

(businesspress24) -
Toronto, Ontario - January 27, 2020 - EuroLife Brands (CSE: EURO) (FSE: 3CMA) (OTCPK: EURPF) (EuroLife or the Company), a vertically integrated enterprise focused on the pan European hemp, cannabinoid, and health & wellness sector, is pleased to announce it has entered into a definitive financing agreement (the "Agreement") with European Equity Group, an international merchant bank with a primary focus on growth oriented small-cap companies, to secure a credit facility (the "Facility") in the amount of up to $2.5 million CDN (approximately 1,700,000). The Facility provides EuroLife with the capital and flexibility required to continue its expansion across Europe and carry out its corporate objectives for 2020 and 2021. EuroLife intends to use the Facility to continually fund expansion across Europe and for general working capital purposes.

The credit facility with European Equity Group ensures EuroLife has access to sufficient and timely capital to execute on our corporate strategy and maximize shareholder value for the foreseeable future, said Shawn Moniz, CEO of EuroLife. "We have secured favourable credit terms with the European Equity Group as we focus on our goal of becoming a vertically integrated cannabis company operating in the hemp, CBD and health & wellness sectors."

Pursuant to the Agreement, the Company may request up to $100,000.00 CDN per month from European Equity Group in exchange for the issuance of units (the Units) of the Company. Each Unit will consist of common shares (the Shares) of the Company and common share purchase warrants (the Warrants).

The Shares may be issued at a maximum of 10% discount to the 20-day VWAP of the Companys Shares. The Warrants will be issued at a 50% premium to the price of the Units. All securities issued by the Company to European Equity Group will be subject to a four-month hold period.

EuroLife previously announced an intent (LOI) to acquire a 20% interest in a state-of-the-art industrial hemp cultivation operation located near Dresden, Germany. The operation consists of a robust portfolio of assets including prime agricultural land, cultivation equipment, post production facilities, and inventory. When acquired the ownership position will be EuroLifes key asset and one of the largest fully operational outdoor hemp cultivation projects in Europe. Upon finalizing the definitive purchase agreement for the interest in the Dresden hemp operations, which is expected to be finalized in Q1 2020, the partners look to maximize the value of the approximately 110,000 kilograms of existing hemp biomass.

Additionally in 2019, EuroLife announced further progression into the European markets. Derek Ivany, chairman of the Eurolife advisory board, has continued to expand the Eurolife presence in Europe by leveraging existing networks and entering into a corporate advisory agreement with JJ Wolf Investments Ltd., a merchant banking and advisory firm that has been tasked with establishing a physical foothold within premium CBD (cannabidiol) markets in Europe on behalf of Eurolife.

Wolf has been mandated with furthering the Eurolife business and brand across Europe and South America through various value enhancing corporate actions. Principals of Wolf have been involved in a variety of successful transactions for companies in the cannabis-hemp industry, delivering on value-added targeted acquisitions and increasing shareholder value through revenue-generating opportunities. EuroLife and JJ Wolf have made significant progress in its endeavour to expand aggressively into Europe and this is evident from the financial commitment set forth by European Equity Group.

About EuroLife Brands Inc.

EuroLife Brands (CSE: EURO) (FSE: 3CMA) (OTCPK: EURPF) is a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics.

For additional information:
Contact: ir(at) or visit

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuers future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Companys Managements Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on

More information:
http://https:// https://

Keywords (optional):

Company information / Profile:

PressRelease by


PressContact / Agency:

published by: irw
print pressrelease  send to a friend  

Date: 01/27/2020 - 11:42
Language: English
News-ID 1555470
Character count: 1269
Firma: EuroLife Brands Inc.
Ansprechpartner: Feedback to about Pressrelease-id:
Stadt: Wien


Number of hits: 244


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 437
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 64

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.


[ more PressReleases ][ RSS-Feed ]